AGI Dermatics

AGI Dermatics raises $5.5 million in series A financing

Published in Lab Business Week, November 12th, 2006

AGI Dermatics, a privately held biopharmaceutical company focused on skin cancer prevention drugs and anti-aging topical skin care products, announced it has raised $5.5 million in a Series A private equity round.

Trevi Health Ventures led the round, which included WHI Group and select private investors. In conjunction with the financing, Andrew Fink, managing director of Trevi, and Steven Kaye, an investor in Trevi, will join AGI's board of directors.

"We are very pleased with this strong interest in our program for commercialization of our technology," said Daniel B. Yarosh, PhD, AGI Dermatics' president and CEO. "Enthusiasm for this financing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-11-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry